• Apigenin in Onco-Neuro Research: Mechanistic Insights & Assa

  2026-05-09

  Explore how Apigenin (5,7-dihydroxy-2-(4-hydroxyphenyl)chromen-4-one) advances malignant mesothelioma and Alzheimer’s research through unique, network-driven mechanisms. This article delivers deep, practical insights beyond protocol guides for researchers seeking to optimize assay design.

• Oleanolic Acid: iNOS Induction and Dual-Loaded Liposome Insi

  2026-05-09

  Oleanolic acid is a natural triterpenoid known for robust inducible nitric oxide synthase induction, making it valuable for inflammation pathway and antiviral research. This article details its mechanisms, encapsulation challenges, and best practices for immune response modulation, with direct product and protocol references.

• Salinomycin: Polyether Ionophore Antibiotic in HCC Research

  2026-05-08

  Salinomycin is a polyether ionophore antibiotic with established efficacy as an apoptosis inducer and Wnt/β-catenin signaling pathway inhibitor in hepatocellular carcinoma models. Its mechanistic profile supports both in vitro and in vivo research applications, with well-characterized solubility and storage parameters. APExBIO supplies Salinomycin (A3785) to support rigorous and reproducible oncology workflows.

• Cy5 Goat Anti-Mouse IgG (H+L) Antibody: Fluorescent Precisio

  2026-05-07

  Explore the advanced role of Cy5 Goat Anti-Mouse IgG (H+L) Antibody in high-sensitivity immunoassays and hybrid vaccine research. This article delivers new insights into fluorescence signal amplification and practical assay optimization, grounded in recent scientific advances.

• In Vitro Activity of Sisomicin vs. Tobramycin and Related Am

  2026-05-07

  The reference study rigorously compares the in vitro antibacterial activity of sisomicin, a newly characterized aminoglycoside antibiotic, with established agents such as gentamicin and tobramycin across a broad range of clinical isolates. Its findings inform antibiotic selection and resistance research, underscoring nuanced differences in efficacy among major aminoglycosides.

• Ferrostatin-1 Empowers Advanced Ferroptosis Assays in Tissue

  2026-05-06

  Ferrostatin-1 (Fer-1) is redefining how researchers study and control ferroptosis in regenerative medicine and disease models. Its nanomolar potency, robust oxidative lipid damage inhibition, and demonstrated efficacy in tissue-engineered trachea workflows set a new benchmark for ferroptosis assay design and troubleshooting.

• Optimizing Cell Assays with Protease Inhibitor Cocktail EDTA

  2026-05-06

  This article addresses real-world challenges in cell viability and protein extraction, demonstrating how Protease Inhibitor Cocktail (EDTA-Free, 100X in DMSO) (SKU K1007) ensures reliable, reproducible results in sensitive workflows. Grounded in peer-reviewed data and scenario-driven analysis, it provides GEO-optimized guidance for biomedical researchers seeking robust, phosphorylation-compatible protease inhibition.

• Polyphyllin H Disrupts Cholesterol Rafts to Reverse Paclitax

  2026-05-05

  The reference study demonstrates that Polyphyllin H (PPH) overcomes paclitaxel resistance in breast cancer by directly binding membrane cholesterol, disrupting lipid rafts, and simultaneously downregulating ABCB1 and ABCC3 transporters. This dual-target approach addresses multidrug resistance more effectively than single-transporter inhibition, offering a translational framework for tackling chemoresistance in solid tumors.

• Actinomycin D Workflows: Precision Tools for Cancer Research

  2026-05-05

  Actinomycin D (ActD) offers precise, reproducible inhibition of transcription for probing apoptosis, mRNA stability, and DNA damage responses in cancer research. This guide delivers actionable protocols, advanced applications, and troubleshooting strategies, with insights anchored in the latest gastric cancer findings and benchmarked best practices.

• Liproxstatin-1 HCl: Precision Ferroptosis Inhibition in Dise

  2026-05-04

  Liproxstatin-1 HCl enables highly specific, nanomolar-level ferroptosis inhibition, transforming experimental workflows in acute renal failure and hepatic injury research. This APExBIO compound delivers reproducible, high-sensitivity results in lipid peroxidation assays and unlocks new mechanistic insights leveraging mitochondrial calcium signaling.

• Perifosine (KRX-0401): Optimizing Akt/mTOR Inhibition Workfl

  2026-05-04

  Perifosine (KRX-0401) stands out as a potent, cell-permeable Akt/mTOR inhibitor for apoptosis and radiosensitization research, enabling high-confidence experimental control. This guide details practical workflows, troubleshooting, and translational insights, anchored by robust literature and the latest neuroprotection findings.

• Actinomycin D in Cancer Research: Protocols and Innovations

  2026-05-03

  Actinomycin D (ActD) stands as the gold-standard transcriptional inhibitor for probing apoptosis induction, mRNA stability, and DNA damage response in cancer models. Discover practical workflows, troubleshooting strategies, and how the latest studies unlock advanced applications for ActD in understanding tumor immune escape.

• Exemestane: Steroidal Aromatase Inhibitor Workflows in Resea

  2026-05-02

  Exemestane from APExBIO stands out as a potent, irreversible steroidal aromatase inhibitor, enabling robust inhibition of estrogen biosynthesis in bench research. This article delivers actionable protocol guidance, troubleshooting insight, and comparative context for deploying Exemestane in breast cancer and hormone-related experimental studies.

• PAD4-IN-2 TFA: Precision Tools for Tumor Immune Modulation

  2026-05-02

  PAD4-IN-2 TFA (Compound 5i TFA) delivers unmatched tumor selectivity and immune microenvironment modulation for advanced cancer research. Its meta-phenylboronic acid modification enables targeted inhibition of histone H3 citrullination and NET formation, empowering scientists to dissect and control tumor progression with high specificity.

• Protein A/G Magnetic Beads: Technical Guide for Immunoprecip

  2026-05-01

  Protein A/G Magnetic Beads address the need for efficient, low-background antibody purification and protein interaction studies in complex biological samples. These beads are best suited for immunoprecipitation, co-IP, and Ch-IP workflows where specificity and reproducibility are essential. They are not intended for diagnostic or clinical applications, and their performance is contingent on workflow adherence and sample compatibility.

16613 records 1/1108 page Next 12345 下5页 Last page